New Milford Hospital in Connecticut will pay almost $472,000 to resolve allegations that it overbilled Medicare by incorrectly billing injections of leuprolide acetate, commonly known as Lupron.  Lupron is used to treat both prostate cancer in men and endometriosis and fibroids in women.  Because the uses for women require higher doses than for the male uses, female injections are reimbursed at a higher rate.  According to the complaint, although the hospital eventually discovered that it had billed male injections as female injections, it failed to notify Medicare and return the overpayment within 60 days as required by the False Claims Act.

Read the entire article, “New Milford Hospital 3rd in state to settle claims it overbilled Medicare”